Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2-positive × Trastuzumab × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Gastrointestinal 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 3 Solid Tumors 2 Solid Tumor 2 Solid Tumor, Adult 1 Relapsed Pediatric Solid Tumor 1 Malignant Solid Neoplasm 1 HER2-positive 1 HER2+ Advanced Breast Cancer 1

Interventions

sintilimab 1 Trastuzumab 1 S 1 (combination) 1 Oxaliplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05218148 2022-04-06

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

ChineseAMS

Phase 2 Unknown

GastrointestinalOther solid neoplasm

HER2-positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡